+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Carbamazepine"

Grand Mal Seizure Treatment Global Market Report 2024 - Product Thumbnail Image

Grand Mal Seizure Treatment Global Market Report 2024

  • Report
  • February 2024
  • 175 Pages
  • Global
From
Anticonvulsants Global Market Report 2024 - Product Thumbnail Image

Anticonvulsants Global Market Report 2024

  • Report
  • January 2024
  • 200 Pages
  • Global
From
From
Trigeminal Neuralgia - Pipeline Insight, 2024 - Product Thumbnail Image

Trigeminal Neuralgia - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Epilepsy Forecast and Market Analysis to 2035 - Product Thumbnail Image

Epilepsy Forecast and Market Analysis to 2035

  • Drug Pipelines
  • July 2019
  • 345 Pages
  • Global
From
From
2020 Carbamazepine Test Volume and Sales Forecasts: US, Europe, Japan - Hospitals, Commercial Labs, POC Locations - Product Thumbnail Image

2020 Carbamazepine Test Volume and Sales Forecasts: US, Europe, Japan - Hospitals, Commercial Labs, POC Locations

  • Report
  • February 2020
  • Japan, United States, ... Japan, United States, Europe
From
From
From
From
Antiepileptic Drugs Market - Forecast (2022 - 2027) - Product Thumbnail Image

Antiepileptic Drugs Market - Forecast (2022 - 2027)

  • Report
  • January 2022
  • 137 Pages
  • Global
From
The Treatment of Epilepsy. 3rd Edition - Product Thumbnail Image

The Treatment of Epilepsy. 3rd Edition

  • Book
  • July 2009
  • 1116 Pages
  • 20 Results (Page 1 of 1)
Loading Indicator

Carbamazepine is a drug used to treat epilepsy and other neurological disorders. It is classified as an anticonvulsant and is used to treat seizures, trigeminal neuralgia, and bipolar disorder. It works by decreasing the activity of certain nerve cells in the brain, which helps to reduce the frequency and severity of seizures. It is also used to treat certain types of pain, such as trigeminal neuralgia. Carbamazepine is a member of the Central Nervous System (CNS) drug class, which includes drugs used to treat neurological disorders. Carbamazepine is available in both generic and brand-name forms. It is available in tablet, capsule, and liquid forms, and is usually taken twice a day. The dosage and duration of treatment depend on the condition being treated. Common side effects of carbamazepine include dizziness, drowsiness, nausea, and vomiting. Some companies in the Carbamazepine market include Mylan, Teva Pharmaceuticals, and Sun Pharmaceuticals. Show Less Read more